| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 05/04/2004 | US6730315 Medium and matrix for long-term proliferation of cells |
| 05/04/2004 | US6730304 Viral nuceotide sequences for use in the diagnosis of viral diseases |
| 05/04/2004 | US6730269 Nanoparticles having oligonucleotides attached thereto and uses therefor |
| 05/04/2004 | US6730200 Electrochemical sensor for analysis of liquid samples |
| 05/04/2004 | CA2296178C Human intestinal npt2b |
| 05/01/2004 | CA2410795A1 A method for the amplification of multiple genetic targets |
| 04/30/2004 | CA2446175A1 Micro/nano-structures fabricated by laser ablation for micro-array applications |
| 04/30/2004 | CA2444645A1 Cell culture device |
| 04/30/2004 | CA2444200A1 Microfluidic system for analyzing nucleic acids |
| 04/29/2004 | WO2004036224A2 Screening method |
| 04/29/2004 | WO2004036221A2 Compositions and methods for diagnosing and treating autoimmune disease |
| 04/29/2004 | WO2004036219A1 Demethylated and/or oxidized membrane dna and use thereof in the diagnostic of autoimmune diseases |
| 04/29/2004 | WO2004036190A2 Compositions and methods for detecting west nile virus |
| 04/29/2004 | WO2004036188A2 Processes for identifying quadruplex-targeted antiviral molecules |
| 04/29/2004 | WO2004036185A2 Diagnosis and treatment of herpes simplex virus diseases |
| 04/29/2004 | WO2004036184A2 Method for drying dye-terminator sequencing reagents |
| 04/29/2004 | WO2004036183A2 Analyte sensors and methods for making them |
| 04/29/2004 | WO2004036179A2 High throughput detection of glutathione s-transferase polymorphic alleles |
| 04/29/2004 | WO2004036177A2 Assays to detect or quantify bacterial or viral pathogens and contaminants |
| 04/29/2004 | WO2004036176A2 Biosensor |
| 04/29/2004 | WO2004036172A2 Bioweapon-detecting fibrous-network products and methods for making same |
| 04/29/2004 | WO2004036171A2 Disease detection by digital protein truncation assays |
| 04/29/2004 | WO2004035835A2 Method for quantitative end-point pcr |
| 04/29/2004 | WO2004035834A1 Method using indium tin oxide substrate in high throughput screening |
| 04/29/2004 | WO2004035833A1 Methods for assessing efficacy of chemotherapeutic agents |
| 04/29/2004 | WO2004035832A1 Method for detecting mutations |
| 04/29/2004 | WO2004035831A1 Method for identifying vehicle and oligonucleotide marker used therefor |
| 04/29/2004 | WO2004035830A1 METHOD OF EVALUATING β-CELL HYPOFUNCTION IMPROVING AGENT |
| 04/29/2004 | WO2004035829A1 Probes for detecting gene and method of electrochemically detecting gene |
| 04/29/2004 | WO2004035828A2 Diagnostic and therapeutic means for kidney stone related pathologies |
| 04/29/2004 | WO2004035827A2 Microarrays allowing molecular profiling of rheumatoid arthritis comparatively to osteoarthritis andtheir use |
| 04/29/2004 | WO2004035826A1 Association of the h2 haplotype of the p2y12 receptor with an increased risk for thrombosis and peripheral arterial disease |
| 04/29/2004 | WO2004035825A2 Marker gene |
| 04/29/2004 | WO2004035824A2 Method of detecting polymorphisms affecting transcriptional activity |
| 04/29/2004 | WO2004035823A2 Diagnostic and therapeutic use of the nicotinamide mononucleotide adenylytransferase 2 (nmnat-2) gene and protein for neurodegenerative diseases |
| 04/29/2004 | WO2004035822A1 Methods to predict edema as a side effect of drug treatment |
| 04/29/2004 | WO2004035821A1 Assay methods for detection of a virus in an avian tissue sample |
| 04/29/2004 | WO2004035820A1 Genetic markers for diagnosing the splay leg phenotype expression in domestic animals, breeding animals, and working animals |
| 04/29/2004 | WO2004035819A2 Oligonucleotide analogues for detecting and analyzing nucleic acids |
| 04/29/2004 | WO2004035818A1 Use of osmolytes to heat stabilise luciferase and/or apyrase |
| 04/29/2004 | WO2004035817A1 Method and reagent for measuring cholesterol in high-density lipoproteins |
| 04/29/2004 | WO2004035816A1 Method and reagent for measuring cholesterol in high density lipoproteins |
| 04/29/2004 | WO2004035815A1 Modulation of s6 kinase activity for the treatment of obestiy |
| 04/29/2004 | WO2004035814A1 Use of 4-galactosyl-xylose in humans for the in vivo evaluation of intestinal lactase as a non-invasive diagnostic test of the deficiency of said enzyme |
| 04/29/2004 | WO2004035813A2 Screening molecules with anti-prion activity: kits, methods and screened molecules |
| 04/29/2004 | WO2004035812A2 Asparaginyl hydroxylases and modulators thereof |
| 04/29/2004 | WO2004035811A2 Kinase modulation assay |
| 04/29/2004 | WO2004035810A2 Verfahren zur bestimmung der enzymatischen aktivität des lytb- und gcpe-proteins |
| 04/29/2004 | WO2004035809A1 Rapid coliform detection system |
| 04/29/2004 | WO2004035808A2 Method for detecting viral inactivating agents |
| 04/29/2004 | WO2004035806A2 Methods and nucleic acids for the analysis of cpg dinucleotide methylation status associated with the calcitonin gene |
| 04/29/2004 | WO2004035805A2 Differential patterns of gene expression that predict for docetaxel chemosensitivity and chemoresistance |
| 04/29/2004 | WO2004035803A2 Method and nucleic acids for the treatment of breast cell proliferative disorders |
| 04/29/2004 | WO2004035789A1 Gene families associated with cancers |
| 04/29/2004 | WO2004035788A1 Novel genes and proteins encoded thereby |
| 04/29/2004 | WO2004035784A2 Soluble rna polymerase protein and methods for the use thereof |
| 04/29/2004 | WO2004035778A1 Substrates specific to von willebrand factor cleaving protease and method of assaying the activity |
| 04/29/2004 | WO2004035770A1 Crystal structure of staphylococcus undecaprenyl pyrophosphate synthase and uses thereof |
| 04/29/2004 | WO2004035753A2 Lmna gene and its involvement in hutchinson-gilford progeria syndrome (hgps) and arteriosclerosis |
| 04/29/2004 | WO2004035748A2 Methods using gene trapped stem cells for marking pathways of stem cell differentiation and making and isolating differentiated cells |
| 04/29/2004 | WO2004035746A2 Susceptibility gene for myocardial infarction |
| 04/29/2004 | WO2004035741A2 Susceptibility gene for myocardial infarction; methods of treatment |
| 04/29/2004 | WO2004035733A2 Isolated human hepsin/46 proteins, nucleic acid molecules encoding human hepsin/46 proteins, and uses thereof |
| 04/29/2004 | WO2004035611A2 Peptides binding the phosphatase 2a protein and polynucleotides encoding same |
| 04/29/2004 | WO2004035597A2 Methods of assessing the risk of reproductive failure by measuring telomere length |
| 04/29/2004 | WO2004035139A1 Regulation of mkk3 |
| 04/29/2004 | WO2004035088A1 Therapeutics/diagnostics for brain tumor |
| 04/29/2004 | WO2004034994A2 Methods and compositions for determining risk of treatment toxicity |
| 04/29/2004 | WO2004034969A2 Functional sites |
| 04/29/2004 | WO2004026109A3 Molecular targets of cancer and aging |
| 04/29/2004 | WO2004023143A3 Analytical platform and identification method |
| 04/29/2004 | WO2004020979A9 Methods of assaying for cell cycle modulators using components of the ubiquitin ligation cascade |
| 04/29/2004 | WO2004016800A3 Assay for low molecular weight heparin |
| 04/29/2004 | WO2004015420B1 Method for diagnosing multiple sclerosis |
| 04/29/2004 | WO2004015107A3 Further novel forms of interfering rna molecules |
| 04/29/2004 | WO2004013275A3 Stem cells derived from adipous tissue and differentiated cells derived from said cells |
| 04/29/2004 | WO2004012675A3 Lipid binding molecules and methods of use |
| 04/29/2004 | WO2004011491A3 Peptidyl-trna hydrolase of enterococcus faecalis |
| 04/29/2004 | WO2004007770A3 Method for diagnosis of intestinal-type gastric tumors |
| 04/29/2004 | WO2004007706A8 Plant nucleotide-sugar pyrophosphatase/phosphodiesterase (nppase), method of obtaining same and use of same in the production of assay devices and in the production of transgenic plants |
| 04/29/2004 | WO2004005920A3 Method for enriching and tracking pathologic modified prions-proteins (prpsc) |
| 04/29/2004 | WO2004005534A3 Screening for alzheimer's disease |
| 04/29/2004 | WO2004005451A3 Method for detecting the von willebrand factor-cleaving protease activity of adamts-13 |
| 04/29/2004 | WO2004003185A3 Plant deoxyribonucleoside kinase enzymes and their use |
| 04/29/2004 | WO2003104485A3 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue |
| 04/29/2004 | WO2003089805A3 Collision energy-absorbing device |
| 04/29/2004 | WO2003087408A3 Schizophrenia associated genes |
| 04/29/2004 | WO2003087368A3 Means and methods for the specific modulation of target genes in the cns and the eye and methods for their identification |
| 04/29/2004 | WO2003087367A3 Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye |
| 04/29/2004 | WO2003087341A3 Targeted chromosomal mutagenesis using zinc finger nucleases |
| 04/29/2004 | WO2003083127A3 Method and system for determining absolute mrna quantities |
| 04/29/2004 | WO2003078565A9 Cell motility and chemotaxis test device and methods of using same |
| 04/29/2004 | WO2003060147A3 Method of obtaining purified enterochromaffin cells and methods of using same |
| 04/29/2004 | WO2003060127A3 Genes and proteins involved in the biosynthesis of lipopeptides |
| 04/29/2004 | WO2003060087A3 Rapid method of selecting cells for gene disruption by homologous recombination |
| 04/29/2004 | WO2003057912A3 Molecular trichogram |
| 04/29/2004 | WO2003052374A8 Methods for identifying racemases |
| 04/29/2004 | WO2003048187A3 Peptides and use thereof in therapeutic agents against hiv infection |
| 04/29/2004 | WO2003042399A9 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof |
| 04/29/2004 | WO2003033724A3 Nucleic acid amplification |